Volume 136, Issue 6 pp. 930-932

Active psoriasis and profound CD4+ lymphocytopenia

C.M HARDMAN

C.M HARDMAN

Departments of St Mary's Hospital, Praed Street, London W2 1NY, U.K.

Search for more papers by this author
B.S BAKER

B.S BAKER

Departments of St Mary's Hospital, Praed Street, London W2 1NY, U.K.

Search for more papers by this author
J. LORTAN

J. LORTAN

Departments of Dermatology St Mary's Hospital, Praed Street, London W2 1NY, U.K. Dermatology

Search for more papers by this author
J. BREUER

J. BREUER

Department of Virology, the Royal London Hospital, London, U.K.

Search for more papers by this author
T. SURENTHERAN

T. SURENTHERAN

Department of Virology, the Royal London Hospital, London, U.K.

Search for more papers by this author
A. POWLES

A. POWLES

Departments of St Mary's Hospital, Praed Street, London W2 1NY, U.K.

Search for more papers by this author
L. FRY

L. FRY

Departments of St Mary's Hospital, Praed Street, London W2 1NY, U.K.

Search for more papers by this author
First published: 28 June 2008
Citations: 7

Summary

We report the case of a patient with a long-standing history of widespread chronic plaque psoriasis, who was recently found to have a profound CD4+ lymphocytopenia. He is human immunodeficiency virus (HIV) negative. His psoriasis remains active and widespread, and he has had 60 cutaneous malignancies, including many squamous cell carcinomas, excised over the last 10 years. In the past he has had numerous cutaneous viral warts. Despite a low peripheral blood CD4+ T-cell count, similar numbers of activated T cells, identified by double labelling for CD4 and HLA-DR antigens, were found in the epidermis of our patient as other individuals with psoriasis. Thus, there appear to be sufficient activated CD4+ T cells in our patient's psoriatic plaques to maintain the psoriatic process.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.